n(1)-methylnicotinamide has been researched along with Insulinoma in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Przygodzki, T | 1 |
| Slominska, E | 1 |
| Polakowska, E | 1 |
| Mlynarski, W | 1 |
| Watala, C | 1 |
1 other study available for n(1)-methylnicotinamide and Insulinoma
| Article | Year |
|---|---|
Effects of 1-methylnicotinamide and its metabolite N-methyl-2-pyridone-5-carboxamide on streptozotocin-induced toxicity in murine insulinoma MIN6 cell line.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Cell Survival; Insulinoma; Mice; NAD; Niacinamide | 2011 |